Engineered Cancer-Killing Viruses Move From Lab Curiosity to Approved Therapy
A new review details how engineered oncolytic viruses selectively kill tumors, ignite antitumor immunity, and where clinical translation still falls ...
A new review details how engineered oncolytic viruses selectively kill tumors, ignite antitumor immunity, and where clinical translation still falls ...
A three-component nanoparticle that consumes tumor glucose and triggers pyroptosis and cuproptosis suppressed liver cancer growth and established immune memory ...
A ROS-responsive nanoparticle co-delivering a PARP inhibitor prodrug and a DOT1L inhibitor amplified DNA damage, activated cGAS-STING signaling and improved ...
New research shows that the TREX1 exonuclease suppresses anti-tumor immunity in mice by degrading short, MRE11-derived cytosolic DNA fragments that ...
A new review describes how prostate cancer reverses its specialized citrate-producing metabolism and how extracellular vesicles may transfer metabolic signals ...
In preclinical castration-resistant prostate cancer models, combining B7-H3 blockade with the MEK inhibitor trametinib overcame compensatory immune suppression and structural ...
Carbonic anhydrases are zinc-containing metalloenzymes that catalyze the reversible hydration of carbon dioxide to bicarbonate and a proton, a reaction ...
A self-assembling nanomedicine combining orlistat and chlorin e6 rewires fat metabolism in triple-negative breast cancer to amplify ferroptosis, boost photodynamic ...
A new mouse study shows that gentle, non-ablative focused ultrasound delivered before radiation therapy reprograms the breast tumor microenvironment, boosting ...
A new narrative review synthesizes clinical trial evidence showing that combining PD-1/PD-L1 immune checkpoint inhibitors with chemotherapy, radiotherapy, and surgery ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine